Incyte is focused on advancing biopharmaceutical innovation.
Founded in 2002 with a small number of scientists, chemists and biologists in Wilmington, Delaware, Incyte has grown into a global organization with a robust portfolio of treatments across Hematology, Oncology and Inflammation and Autoimmunity. Today, the company has more than 2,800 employees and operations in 13 countries across North America, Europe and Asia.
Our goal is to develop breakthrough medicines that improve patients' lives. With patients at the center of everything we do, our discovery approach focuses on building a portfolio of compounds that are scientifically differentiated and poised to make a meaningful impact.
At Incyte, we aim to foster a workplace grounded in respect, curiosity and accountability. We are proud to have been named among the Top Employers by Science magazine for 8 consecutive years, as well as being named one of the Global Top 100 Most Loved Workplaces and America’s Top 100 Most Loved Workplaces by Newsweek and the Best Practice Institute.
To learn more, visit Incyte.com and Investor.Incyte.com. Follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.
See our Community Guidelines: http://bit.ly/2sV0H5W
Jazz Pharmaceuticals plc (Nasdaq: JAZZ), is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are focused on developing life-changing medicines for people with rare diseases—often with limited or no options—so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, we are working to give people around the world the opportunity to redefine what’s possible – to make the “small wins” big again.
Founded in 2003, we maintain a highly collaborative culture where employees focus on how they can be successful and accomplish positive results by exemplifying the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence.
Together, we are experts, analysts, specialists, advocates, scientists and professionals all with diverse backgrounds and perspectives. Working together, we are proud to support patients, innovate and bring new medicines to patients with critical unmet needs in rare disease.
Please see our website at www.jazzpharma.com for more information. For information on recruitment, please visit https://careers.jazzpharma.com/. For guidelines on engaging with Jazz on social media, please visit https://bit.ly/2OaMOuq.
argenx is a global immunology company committed to improving the lives of people living with severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx is translating immunology breakthroughs into a world-class portfolio of novel antibody-based medicines.